Tudor Investment Corporation »

Maplight Therapeutics shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Maplight Therapeutics (MPLT) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Maplight Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Maplight Therapeutics held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maplight Therapeutics by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2025-12-31 $840k 48k 17.57

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)
Invesco Qqq Trust Series 1 - US ETP ETF Option Call Option (QQQ)
State Street SPDR S&P 500 ETF Trust - US ETP ETF Option Call Option (SPY)
Nvidia Corp - US Equity (NVDA)
Microsoft Corp - US Equity (MSFT)
Ishares Core S&P 500 Etf - US ETP ETF Option Call Option (IVV)
State Street Energy Select Sector SPDR ETF - US ET ETF Option Call Option (XLE)
Apple Inc - US Equity (AAPL)
Alphabet Equity (GOOGL)
Amazon.Com Inc - US Equity (AMZN)
Meta Platforms Inc - US Equity Option Call Option (META)
Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)
State Street Financial Select Sector SPDR ETF - US ETF Option Call Option (XLF)
State Street Utilities Select Sector SPDR ETF - US ETF Option Call Option (XLU)
Spdr Gold Shares - US ETP ETF Option Call Option (GLD)

View all positions for Tudor Investment Corporation

Top funds holding Maplight Therapeutics

Novo A/S
Fcpm Iii Services B.v.
T. Rowe Price Investment Management
Goldman Sachs Group
BlackRock
Nan Fung Group Holdings
5AM Venture Management
Sanofi
Vanguard Group
Pivotal bioVenture Partners Investment Advisor
Perceptive Advisors
Velan Capital Investment Management
Siren
Geode Capital Management
Vestal Point Capital

View all funds holding Maplight Therapeutics